Condition
Tuberculous Meningitis clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Tuberculous Meningitis clinical trials that are recruiting, at sites in 18 countries (most in Uganda (2), South Africa (2), Brazil (2)). 1 was first registered in the last 30 days. By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 18Countries
Newest Tuberculous Meningitis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Tuberculous Meningitis in Indonesia: Characteristics, Treatments, Diagnostics, and Outcomes (2022–2025) | — | Denpasar, Bali and 5 other locations | Recruiting | Nov 10, 2026 |
| BPaLMZ for TB Meningitis: a two-stage trial comparing an experimental regimen to standard therapy | Phase 2 | Kampala and 1 other locations | Recruiting | Nov 13, 2025 |
| Using adalimumab to improve survival in HIV patients with tuberculosis meningitis | Phase 2 | Rio de Janeiro and 2 other locations | Recruiting | Oct 21, 2022 |
| Six-month high-dose rifampicin and isoniazid with linezolid and pyrazinamide versus standard nine-month therapy for adult and adolescent tuberculous meningitis | Phase 2 | Porto Alegre and 17 other locations | Recruiting | May 20, 2022 |
| Intensified treatment for tuberculous meningitis to reduce mortality | Phase 3 | Abidjan and 12 other locations | Recruiting | Oct 30, 2019 |
All recruiting trials (5)
-
Tuberculous Meningitis in Indonesia: Characteristics, Treatments, Diagnostics, and Outcomes (2022–2025)
This study looks back at TB meningitis patients treated in several Indonesian hospitals from 2022 to 2025 to describe their symptoms, tests, treatments, and outcomes using existing medical records.
-
BPaLMZ for TB Meningitis: a two-stage trial comparing an experimental regimen to standard therapy
This phase 2 trial tests whether the BPaLMZ combination can be better than standard TB meningitis treatment in adults living with HIV who have TB meningitis.
-
Using adalimumab to improve survival in HIV patients with tuberculosis meningitis
This study is testing if adding a medication called adalimumab to the usual treatment can help HIV patients with tuberculosis meningitis live longer and stay safe.
-
Six-month high-dose rifampicin and isoniazid with linezolid and pyrazinamide versus standard nine-month therapy for adult and adolescent tuberculous meningitis
This study tests whether a six-month, high-dose antibiotic regimen (rifampicin, isoniazid, linezolid, and pyrazinamide) works better than the WHO nine-month treatment for adults and adolescents with tuberculous meningitis.
-
Intensified treatment for tuberculous meningitis to reduce mortality
This study is testing if a stronger treatment for tuberculous meningitis can help people survive better than the standard treatment.
Related topics
Quick answers
How many Tuberculous Meningitis clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 18 countries. The most sites are in Uganda (2 trials), South Africa (2 trials), Brazil (2 trials), Indonesia (1 trial), Côte d’Ivoire (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.